FDA publishes guidance on abuse-resistant opioids
January 14, 2013Manufacturing and Production CDC, FDA, hamburg, opioids
The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …
Lonza earmarks $15m for ADC plant expansion
January 14, 2013Manufacturing and Production ADC, API, Lonza, Novasep
Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …
Kathryn Gallant joins Insight Health US as joint chief executive
January 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gallant, insight health
The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as …
Eisai cancer drug fails
January 14, 2013Research and Development, Sales and Marketing Cancer, Eisai, Morphotek, farletuzumab
Eisai’s investigational oncology treatment farletuzumab has failed to reach its primary endpoint in a late-stage trial. Farletuzumab (MORAb-003) did not …
Merck withdraws Tredaptive
January 14, 2013Sales and Marketing EMA, Merck, tredaptive
Merck is mounting a global operation to withdraw its cholesterol-lowering drug Tredaptive from the market following safety concerns. The company …
Dominic Atkins joins Clinigen GAP in senior commercial role
January 14, 2013Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins
Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …
Janssen’s diabetes drug Invokana recommended
January 11, 2013Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana
An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …
EU submission for GSK and Theravance COPD drug
January 11, 2013Sales and Marketing COPD, GSK, Theravance, UMEC/VI
GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …
Lundbeck appoints new global pricing and market access VP
January 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck
Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …
Public health budget ring-fenced
January 11, 2013Sales and Marketing Hunt, NHS, government
Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …
Cherwell appoints product specialist
January 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cherwell Laboratories
Pharma supplier firm Cherwell Laboratories has announced the appointment of Abdulmajeed Raji as microbiology product specialist. Prior to joining Cherwell, …
FDA vote on J&J diabetes drug
January 10, 2013Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin
Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …
Hookipa Biotech hires two officers
January 10, 2013Manufacturing and Production, Research and Development, Sales and Marketing Farshad Guirakhoo, Hookipa, Thomas Monarth
Vaccines biotech firm Hookipa Biotech AG has appointed two new members to its management team. Thomas Monath (pictured) joins as …
Global agency network welcomes new members
January 10, 2013Medical Communications Indigenus, Lindh & Partners, PharMa International
A global network of independent healthcare agencies has welcomed two new members to the group. Tokyo-based PharMa International and Swedish …
£120m health research boost
January 10, 2013Sales and Marketing Hunt, NHS, NIHR, TXA
The Department of Health is putting £120 million of new funding into health research over the next five years in …
CQC ‘needs urgent overhaul’, say MPs
January 9, 2013Sales and Marketing CQQ, Dorrell, NHS, select committee
England’s health and social care regulator, the Care Quality Commission (CQC), must overhaul its governance structures ‘as a matter of …
Gilead licences MacroGenics technology
January 9, 2013Research and Development, Sales and Marketing DART, Gilead, MacroGenics
Private biotech company MacroGenics has licenced its bi-specific antibody platform technology to Gilead Sciences for products aimed at four unnamed …
MAPI Group hires James Karis as chief executive
January 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing James Karis, MAPI
Healthcare services group MAPI has named James Karis as its chief executive. MAPI looks to Karis to consolidate its success …
SHL to present & exhibit at 10th Annual BIO Asia International Conference
January 9, 2013Manufacturing and Production auto injector, autoinjector, shl events
SHL will be presenting and exhibiting at the upcoming 10th Annual BIO Asia International Conference from January 29-30th in Tokyo, …
Private equity firm pays $195m for contract manufacturer JHP
January 8, 2013Manufacturing and Production CMO, JHP, Warburg Pincus
Private equity group Warburg Pincus has acquired sterile injectable drug manufacturer JHP Pharmaceuticals from its current owner Morgan Stanley. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
